Given the diagnosis phase of patients with CLL, the percentage of common NOTCH1 and SF3B1 mutations, which play an important role in the prognosis of patients, was consistent with global studies. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.